Clinical and functional outcomes of patients with schizophrenia treated with risperidone long-acting injection versus oral antipsychotics
β Scribed by J.M. Olivares; A. Rodriguez Morales; J. Diels; M. Povey; A. Lam; Z. Zhao
- Book ID
- 118439656
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- French
- Weight
- 62 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0924-9338
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective This international, nonβrandomised study evaluated maintained efficacy and safety of Risperidone LongβActing Injectable (RLAI) compared to previous medications. To investigate the possible effect of differences in national health care systems across Europe, the UK subset e
## Abstract ## Objective To investigate changes in cognitive function and clinical features following a switch from oral atypical antipsychotics (AAPs) to longβacting injectable risperidone (LAIR) in patients with schizophrenia. ## Methods Thirtyβsix patients with schizophrenia treated with oral